IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway

M Zhou, H Yu, M Bai, S Lu, C Wang, S Ke… - Cancer …, 2024 - Wiley Online Library
Intrahepatic cholangiocarcinoma (ICC) is a highly malignant and aggressive cancer whose
incidence and mortality continue to increase, whereas its prognosis remains dismal. Tumor …

Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells

Y Guo, F Xie, X Liu, S Ke, J Chen, Y Zhao… - Journal of Molecular …, 2023 - academic.oup.com
Enrichment of regulatory T cells (Tregs) in the tumour microenvironment (TME) has been
recognized as one of the major factors in the initiation and development of resistance to …

SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma

H Xu, A Zhang, C Fang, Q Zhu, W Wang, Y Liu… - Frontiers in …, 2022 - frontiersin.org
Background Glioma is a fatal tumor originating from the brain, which accounts for most
intracranial malignancies. Currently, Immunotherapy has turned into a novel and promising …

A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma

H Liu, J Weng - Gene, 2022 - Elsevier
Background Glioma is one of the most prevalent malignant brain tumors and its incidence is
rising continuously in recent years. Studies suggested that the regulatory mechanism of …

The role of hypoxia-related genes in TACE-refractory hepatocellular carcinoma: Exploration of prognosis, immunological characteristics and drug resistance based on …

X Cheng, J Li, L Feng, S Feng, X Wu, Y Li - Frontiers in Pharmacology, 2022 - frontiersin.org
Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular
carcinoma (HCC). During TACE, chemotherapeutic agents are locally infused into the tumor …

Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma

A Shen, Y Ye, F Chen, Y Xu, Z Zhang, Q Zhao… - Frontiers in …, 2022 - frontiersin.org
Background Advances in tumor immunotherapy have been developed for patients with
advanced recurrent or metastatic (R/M) HNSCC. However, the response of most HNSCC …

Five EMT‐related genes signature predicts overall survival and immune environment in microsatellite instability‐high gastric cancer

M Zhang, C Cao, X Li, Q Gu, Y Xu, Z Zhu, D Xu… - Cancer …, 2023 - Wiley Online Library
Background Microsatellite instability‐high (MSI‐H) subgroup of gastric cancer (GC) is
characterized by a high tumor mutational burden, increased lymphocytic infiltration, and …

Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer

Z Zhang, Z Liang, D Li, L Wang, Y Chen, Y Liang… - Human Cell, 2022 - Springer
As one of important components of tumor microenvironment, CAFs (cancer-associated
fibroblasts) play a vital role in the development and metastasis of bladder cancer. The …

CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L) 1 immunotherapy in triple-negative breast cancer

SY Wu, SW Zhang, D Ma, Y Xiao, Y Liu, L Chen… - Med, 2023 - cell.com
Background The extensive involvement of dendritic cells (DCs) in immune contexture
indicates their potent value in cancer immunotherapy. Understanding DC diversity in patient …

Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma …

Y Peng, D Yin, X Li, K Wang, W Li, Y Huang… - Journal of Cancer …, 2023 - Springer
Purpose Oral squamous cell carcinomas (OSCCs) are primary head and neck malignant
tumours with a high incidence and mortality. However, the molecular mechanisms involved …